resveratrol has been researched along with scopoletin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Haranahalli, K; Ojima, I; Tong, S | 1 |
| Campkin, D; Houston, TA; Kiefel, MJ; Simone, MI; Wood, A | 1 |
2 review(s) available for resveratrol and scopoletin
| Article | Year |
|---|---|
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Cytoskeletal Proteins; Drug Discovery; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 2016 |
Recent results from non-basic glycosidase inhibitors: How structural diversity can inform general strategies for improving inhibition potency.
Topics: Enzyme Inhibitors; Glycoside Hydrolases; Imino Sugars | 2022 |
1 other study(ies) available for resveratrol and scopoletin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |